Weekly News Recap #Phispers
US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations
Public health suffered several setbacks over the last week. First,
the United States formally exited the World Health Organiza...
Impressions : 1994
Merck’s RSV jab shows efficacy in infants; Novo-Lilly weight loss rivalry intensifies as China okays tirzepatide
This was a week when the US President Joe Biden ended his reelection bid, after giving America the Inflation Reduction Act that...
Impressions : 1285
Novo invests US$ 4.1 bn to boost Wegovy, Ozempic supply; Verona’s COPD therapy bags FDA nod
This week saw a couple of developments in the lucrative US market for glucagon-like peptide-1 (GLP-1) drugs that treat diabetes...
Impressions : 1408
Pfizer’s oral Covid drug bags authorization in US; Biogen slashes price of its Alzheimer’s drug by half
In this week’s Phispers, we bring you updates on Biogen’s controversial Alzheimer’s drug, Novartis’ pla...
Impressions : 1884
CDC finds Moderna to be most effective Covid jab; two Indian CROs under FDA lens over data integrity issues
This week, Phispers brings you updates on Covid vaccines,
news on regulatory actions, legal battles involving drugmakers and d...
Impressions : 1642
Mylan’s valsartan facility gets FDA warning letter; US sues Gilead over HIV drug patents
This week, Phispers has news on Mylan’s valsartan facility in India receiving an FDA warning letter for nitrosamine conta...
Impressions : 4479
FDA seeks changes in 180-day exclusivity for generics; Data-integrity concerns at Bayer`s German facility
This week, Phispers brings you news on the FY 2019 budget proposals in the US that seek to change the way generic drugs come to...
Impressions : 3760
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.